Healwell AI (TSE:AID – Get Free Report) was upgraded by equities researchers at Maxim Group to a “strong-buy” rating in a research report issued on Monday,Zacks.com reports.
Separately, Canaccord Genuity Group raised shares of Healwell AI to a “moderate buy” rating in a report on Tuesday, July 28th. Two equities research analysts have rated the stock with a Strong Buy rating and one has assigned a Buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Strong Buy”.
Read Our Latest Analysis on Healwell AI
Healwell AI Stock Performance
Recommended Stories
- Five stocks we like better than Healwell AI
- China’s Athleisure Boom Is Not Lifting Every Brand Equally
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
Receive News & Ratings for Healwell AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healwell AI and related companies with MarketBeat.com's FREE daily email newsletter.
